Board of Pharmacy Specialties
2215 Constitution Avenue, NW
Washington, DC 20037
(202) 429-7591
(202) 429-6304 FAX
www.bpsweb.org

FOR IMMEDIATE RELEASE:
June 28, 2011

Contact:
Ryan Abel
info@bpsweb.org
202-429-6306

BPS Announces Practice Analysis Task Force for Pediatric Pharmacy and Critical Care

Recently, BPS approved role delineation studies in Pain and Palliative Care, Critical Care and Pediatrics. Conducting a role delineation study is a critical step in evaluating a proposed specialty.

The purpose of the role delineation study is to determine whether these three practice areas are based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in these proposed specialties.

If the role delineation studies in these three areas yield information suggestive that Pain and Palliative Care, Critical Care and/or Pediatrics should be recognized as a specialty practice in pharmacy, the criteria outlined in the BPS Petitioner's Guide for Recognition of a Pharmacy Practice Specialty will be followed in the petition for new specialty recognition. The complete process leading to the administration of a certification exam in a new specialty takes approximately three years to complete.

BPS has appointed the following individuals to the practice analysis task force for pediatric pharmacy:

• Sabrina Boehme, Pediatric Clinical Pharmacist/Transplant Pharmacist, Primary Children's Medical Center, and Professor of Pharmacy Practice, University of Southern Nevada, Salt Lake City, UT
• Michelle Caruso, Clinical Specialist, Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
• Elizabeth Farrington, Pharmacist III Pediatrics, New Hanover Regional Medical Center, Betty A. Cameron Women's and Children's Hospital and Clinical Assistant Professor of Pharmacotherapy, UNC Eshelman School of Pharmacy, Wilmington, NC
• Cyrine-Eliana Haidar, Outpatient Solid Tumor/Neuro-oncology Clinical Pharmacist, St Jude Children's Research Hospital, and Assistant Professor, The University of Tennessee Health Science Center College of Pharmacy Memphis, TN
• Jennifer Hamner, Manager for Clinical Pharmacy Services and Program Director PGY1 Residency, The Children's Hospital, Denver, CO
• Kristin Klein, Clinical Pharmacist Pediatric Infectious Disease, University of Michigan Health System/C.S. Mott Children's Hospital and Clinical Assistant Professor, University of Michigan, Ann Arbor, MI
• Robert Kuhn, Pediatric Clinical Pharmacist and Associate Director of Pharmacy Services, Kentucky Children's Hospital; Professor of Pharmacy Practice and Science and Pediatrics, University of Kentucky College of Pharmacy, Lexington, KY
• Sean O'Neill, Medication Safety Officer / Pediatric Critical Care Specialist, The Children's Hospital of Philadelphia, and Course Coordinator, Jefferson School of Pharmacy, Philadelphia, PA
• Kathy Pham, NICU Clinical Specialist & Director, Pharmacy Residency Programs, Children's National Medical Center, Washington, DC
• Stephanie Phelps, Associate Dean Academic Affairs and Professor, Clinical Pharmacy and Pediatric Care Specialist, The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN
• Michael D. Reed, Associate Chairman, Department of Pediatrics, Children's Hospital Medical Center, Akron, OH and Professor of Pediatrics, Northeast Ohio Medical University, Rootstown, OH

BPS has appointed the following individuals to the practice analysis task force for critical care pharmacy:

• Bradley Boucher, Professor and Vice Chair for Institutional Programs, Department of Clinical Pharmacy/Associate professor, Department of Neurosurgery, University of Tennessee Health Science Center, and Clinical Pharmacist, Regional Medical Center at Memphis, Memphis, TN
• Douglas N. Fish, Clinical Specialist, Medical/Surgical Intensive Care Units & Infectious Diseases, Department of Pharmacy Services, University of Colorado Hospital, and Professor and Chair Department of Clinical Pharmacy, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO
• John Lewin, Division Director, Critical Care and Surgery Pharmacies and Pharmacy Services/ Critical Care Clinical Pharmacy Specialist, Neurosciences Critical Care Unit, The Johns Hopkins Hospital and Adjunct Assistant Professor, Department of Anesthesiology and Critical Care Medicine, Division of Neurosciences Critical Care, Johns Hopkins University School of Medicine; Clinical Associate Professor, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD
• Kamila Dell, Assistant Professor Pharmacotherapeutics and Clinical Research, University of South Florida College of Pharmacy, Tampa, FL
• Lori Schirmer, Clinical Pharmacist Specialist, Surgery and Trauma, Iowa Methodist Medical Center and Associate Professor, Clinical Sciences, Drake University, Des Moines, IA
• Mary Hess, Associate Dean, Jefferson School of Pharmacy, Philadelphia, PA
• Hal E. Richards, Clinical Pharmacy Specialist Critical Care/Nutrition Support, St Joseph's-Candler Health System, Savannah, GA
• John Popadopoulos, Associate Professor of Pharmacy Practice/Director of Pharmacotherapy/Critical Care Pharmacist/Assistant Clinical Professor of Medicine, NYU Langone Medical Center and Farber Teaching Attending, Bellevue Hospital and Assistant Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, New York, NY

BPS Executive Director, William M. Ellis commented; "The interest in these proposed specialties has been very high. BPS received almost 300 nominations to serve on the Pediatric Pharmacy and Critical Care Pharmacy Practice Analysis Taskforces. The conduct of this and other role delineation studies demonstrates the active commitment of BPS to recognize pharmacy specialties and certify pharmacists' knowledge and skill at the advanced practice level. The exploration of new specialties is consistent with the increased interest and recognition of BPS specialty certification over the past five years where the number of board certified pharmacists has doubled."

The practice analysis is scheduled for completion during the first quarter of 2012.

For more information on BPS activities including applying for the 2011 examination visit www.bpsweb.org.

About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) is an autonomous Division of the American Pharmacists Association (APhA), founded in January 1976 to recognize specialties and certify pharmacists in specialized areas of pharmacy practice. Six specialties are currently recognized by BPS, including: 1) nuclear pharmacy, since 1978; 2) nutrition support pharmacy, since 1988; 3) pharmacotherapy, since 1988; 4) psychiatric pharmacy, since 1992; and 5) oncology pharmacy, since 1996. The latest BPS specialty, focused on ambulatory care pharmacy, was approved in June 2009, and is scheduled for its first examination in 2011. More than 10,500 pharmacist specialists are currently certified by BPS.